Skip to main content

Table 1 Baseline demographic data and STPI scores at screening and baseline (safety population)

From: Efficacy of 8 mg lidocaine and 2 mg cetylpyridinium chloride (CPC) fixed-combination lozenges on sore throat pain intensity compared with 1 mg lidocaine and 2 mg CPC fixed-combination lozenges in subjects with sore throat due to upper respiratory tract infection: a randomized double-blind parallel-group single-dose study

 

8 mg lidocaine + 2 mg CPC (n = 125)

1 mg lidocaine + 2 mg CPC (n = 125)

Total (N = 250)

Age, years

32.1 ± 12.6

31.6 ± 11.6

31.8 ± 12.1

Gender, n (%)

 Male

58 (46.4)

58 (46.4)

116 (46.4)

Race, n (%)

 Caucasian

124 (99.2)

124 (99.2)

248 (99.2)

Weight, kg

76.9 ± 19.6

78.6 ± 21.4

77.7 ± 20.5

Height, cm

173.2 ± 10.0

173.5 ± 9.8

173.3 ± 9.9

BMI, kg/m2

25.5 ± 5.6

25.9 ± 5.9

25.7 ± 5.7

STPI at screening, mm

71.5 ± 7.0

71.2 ± 6.7

71.4 ± 6.8

STPI at baseline, mm

72.3 ± 6.9

72.2 ± 6.8

72.2 ± 6.8

  1. Data are expressed as mean ± standard deviation unless otherwise stated
  2. CPC cetylpyridinium chloride, BMI body mass index, STPI sore throat pain intensity